Ex-SAC Manager Gets Time To Build Insider Trading Defense
U.S. District Judge Paul G. Gardephe said Martoma’s team could have three more months to look over evidence against their client. Prosecutors have charged Martoma with making $276 million by trading based on advance knowledge of trials on a Wyeth Ltd. and Elan Corp. PLC drug.
If proven, it would be the most profitable insider...
To view the full article, register now.